Zhejiang Supor Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BUPROPION HYDROCHLORIDE USP, with a corresponding US DMF Number 21222.
Remarkably, this DMF maintains an Active status since its submission on December 28, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 20, 2014, and payment made on December 10, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II